| 1 |
Reid G, Lynch JP 3rd, Fishbein MC, Clark NM. Mucormycosis. Semin Respir Crit Care Med. 2020; 41(1): 99-114.
doi: 10.1055/s-0039-3401992
pmid: 32000287
|
| 2 |
Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018; 56(suppl_1): 93-101.
doi: 10.1093/mmy/myx101
pmid: 29538730
|
| 3 |
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012 ;54(Suppl 1): S23-S34.
|
| 4 |
Antoniadou A. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect. 2009; 15(Suppl 5): 55-9.
|
| 5 |
Sipsas NV, Kontoyiannis DP. Occupation, lifestyle, diet, and invasive fungal infections. Infection. 2008; 36(6): 515-25.
doi: 10.1007/s15010-008-8129-5
pmid: 18998051
|
| 6 |
Lelievre L, Garcia-Hermoso D, Abdoul H, Hivelin M, Chouaki T, Toubas D, et al. Posttraumatic mucormycosis: a nationwide study in France and review of the literature. Medicine. 2014; 93(24): 395-404.
doi: 10.1097/MD.0000000000000221
pmid: 25500709
|
| 7 |
Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006; 20(3): 581-607, vi.
doi: 10.1016/j.idc.2006.06.003
|
| 8 |
Jian Y, Wang M, Yu Y, Zhuo Y, Xiao D, Lin S, et al. Treatment and economic burden of mucormycosis in China: case report review and burden estimation. J Clin Pharm Ther. 2022; 47(7): 905-14.
|
| 9 |
Qu J, Liu X, Lv X. Pulmonary mucormycosis as the leading clinical type of mucormycosis in Western China. Front Cell Infect Microbiol. 2021; 11: 770551.
doi: 10.3389/fcimb.2021.770551
|
| 10 |
Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019; 25(1): 26-34.
doi: 10.1016/j.cmi.2018.07.011
|
| 11 |
He J, Sheng G, Yue H, Zhang F, Zhang HL. Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature. BMC Pulm Med. 2021; 21(1): 138.
|
| 12 |
Agrawal R, Yeldandi A, Savas H, Parekh ND, Lombardi PJ, Hart EM. Pulmonary mucormycosis: risk factors, radiologic findings, and pathologic correlation. Radiographics. 2020; 40(3): 656-66.
doi: 10.1148/rg.2020190156
pmid: 32196429
|
| 13 |
Wahba H, Truong MT, Lei XD, Kontoyiannis DP, Marom EM. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis. 2008; 46(11): 1733-7.
doi: 10.1086/587991
pmid: 18419427
|
| 14 |
Lass-Flörl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J, et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis. 2007 ;45(7): e101-e104.
|
| 15 |
Millon L, Larosa F, Lepiller Q, Legrand F, Rocchi S, Daguindau E, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 2013 ;56(10): e95-e101.
|
| 16 |
Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies:guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica. 2013; 98(4):492-504.
|
| 17 |
Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017; 102(3): 433-44.
doi: 10.3324/haematol.2016.152900
pmid: 28011902
|
| 18 |
Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014; 20(Suppl 3): 5-26.
|
| 19 |
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41(5): 634-53.
doi: 10.1086/432579
pmid: 16080086
|
| 20 |
Kennedy KJ, Daveson K, Slavin MA, van Hal SJ, Sorrell TC, Lee A, et al. Mucormycosis in Australia: contemporary epidemiology and outcomes. Clin Microbiol Infect. 2016; 22(9): 775-81.
doi: 10.1016/j.cmi.2016.01.005
|
), Shubin Guo
